Gout is a progressive and chronic disease with three stages. Asymptomatic hyperuricemia, which is often discovered through an incidental lab finding, begins the process. This is a relatively long ...

More than half of patients with gout from the study cohort reported experiencing peripheral neuropathy. A high prevalence of neuropathy exists among patients with gout, with key associations found ...

Although these lesions are typically a late feature of gout, gouty tophi occasionally present early in the course of disease, either as the initial manifestation of gout or within a few years of first ...

The diagnosis of gout sets into motion an assessment and therapeutic program for comorbidities, plus an enduring treatment program for gout-flare treatment and prophylaxis and serum urate lowering.

Over the years, gout has grown in clinical complexity. We see many more cases with iatrogenic factors, multiple comorbidities, advanced age and treatment-refractory hyperuricemia and arthritis (Table ...

Xanthine oxidase inhibitors, primarily allopurinol and febuxostat, are the mainstay of treatment. The goal of chronic gout management includes lowering serum urate levels to below 6 mg/dL. 5 Overall, ...

There are four stages of gout, a common and often painful condition affecting joints, most often the big toe. Gout is a form of inflammatory arthritis caused by hyperuricemia. Hyperuricemia is a ...

The European Alliance of Associations for Rheumatology - recommends that serum urate should be maintained at <6 mg/dL (360 µmol/L) and <5 mg/dL (300 µmol/L) in those with severe gout. But despite ...